Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Over the last 12 months, insiders at Citius Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Citius Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Citius Pharmaceuticals, Inc. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,234,700 shares for transaction amount of $2M was made by Mazur Leonard L (Executive Chairman) on 2019‑09‑27.
2019-09-27 | Executive Chairman | 2.23M 13.7793% | $0.90 | $2M | +20.83% | |||
2019-09-27 | President and CEO | 558,597 3.4443% | $0.90 | $500,000 | +20.83% | |||
2019-04-03 | Executive Chairman | 1.17M 6.2256% | $1.54 | $1.8M | -23.77% | |||
2019-04-03 | President and CEO | 129,450 0.6917% | $1.54 | $200,000 | -23.77% | |||
2018-08-13 | Executive Chairman | 3.14M 27.0206% | $1.27 | $4M | -14.12% | |||
2018-08-13 | President and CEO | 784,314 6.7551% | $1.27 | $1M | -14.12% | |||
2018-03-29 | Executive Chairman | 167,504 1.6135% | $2.98 | $499,999 | -51.29% | |||
2018-03-28 | President and CEO | 2,915 0.0277% | $3.09 | $9,007 | -53.54% | |||
2017-12-19 | Executive Chairman | 213,106 2.6762% | $4.69 | $999,467 | -41.71% | |||
2017-08-24 | Executive Chairman | 11,000 0.2205% | $2.68 | $29,480 | +15.56% | |||
2017-08-08 | Executive Chairman | 421,400 11.6995% | $4.13 | $1.74M | +4.00% | |||
2016-03-30 | director | 10M 6.4441% | $0.60 | $6M | -74.93% |
Mazur Leonard L | Executive Chairman | 10255343 132.7168% | $2.83 | 8 | 0 | <0.0001% |
HOLUBIAK MYRON Z | President and CEO | 1992243 25.7821% | $2.83 | 4 | 0 | <0.0001% |
BlackRock | $7.83M | 4.83 | 8.73M | +3.18% | +$241,085.63 | <0.0001 | |
The Vanguard Group | $6.29M | 3.88 | 7.01M | +1.52% | +$94,116.91 | <0.0001 | |
Geode Capital Management | $2.64M | 1.63 | 2.95M | +5.96% | +$148,599.28 | <0.0001 | |
State Street | $1.98M | 1.22 | 2.21M | +0.1% | +$1,976.75 | <0.0001 | |
Northern Trust | $1.01M | 0.62 | 1.12M | +7.19% | +$67,435.73 | <0.0001 | |
Advisor Group Holdings Inc | $836,681.00 | 0.52 | 932,333 | +<0.01% | +$71.79 | <0.01 | |
Nuveen | $434,876.00 | 0.27 | 484,649 | 0% | +$0 | <0.0001 | |
Charles Schwab | $320,331.00 | 0.2 | 356,994 | 0% | +$0 | <0.0001 | |
BNY Mellon | $287,460.00 | 0.18 | 320,361 | -6.42% | -$19,707.40 | <0.0001 | |
Hightower Advisors | $188,000.00 | 0.12 | 209,855 | +3.37% | +$6,124.08 | <0.0001 | |
Morgan Stanley | $171,982.00 | 0.11 | 191,667 | -21.43% | -$46,921.39 | <0.0001 | |
Inspire Advisors | $141,258.00 | 0.09 | 157,426 | -13.85% | -$22,713.30 | 0.04 | |
RhumbLine Advisers | $140,686.00 | 0.09 | 156,853 | +4.48% | +$6,036.33 | <0.0001 | |
Wealth Advisory Solutions Llc | $135,492.00 | 0.08 | 151,000 | New | +$135,492.00 | 0.04 | |
UBS | $120,748.00 | 0.08 | 134,613 | -2.11% | -$2,601.30 | <0.0001 | |
Arkadios Wealth Advisors | $89,730.00 | 0.06 | 100,000 | 0% | +$0 | 0.01 | |
Blair William Co Il | $86,320.00 | 0.05 | 96,200 | +5.48% | +$4,486.49 | <0.0001 | |
Barclays | $85,000.00 | 0.05 | 94,468 | -44.04% | -$66,902.81 | <0.0001 | |
Deutsche Bank | $77,788.00 | 0.05 | 86,431 | 0% | +$0 | <0.0001 | |
Goldman Sachs | $78,500.00 | 0.05 | 87,485 | -5.48% | -$4,551.09 | <0.0001 | |
Kestra Advisory Services LLC | $72,582.00 | 0.05 | 80,889 | +11.69% | +$7,596.57 | <0.01 | |
Chelsea Counsel Co | $72,951.00 | 0.05 | 81,300 | 0% | +$0 | 0.04 | |
Jane Street Capital | $70,392.00 | 0.04 | 78,449 | -20.51% | -$18,164.87 | <0.0001 | |
New York State Common Retirement Fund | $70,000.00 | 0.04 | 77,990 | 0% | +$0 | <0.0001 | |
Xtx Topco Ltd | $69,636.00 | 0.04 | 77,606 | +510.54% | +$58,230.40 | <0.01 | |
Horst & Graben Wealth Management | $67,945.00 | 0.04 | 75,722 | 0% | +$0 | 0.01 | |
American International Group | $59,488.00 | 0.04 | 66,297 | +8.53% | +$4,676.70 | <0.0001 | |
LINSCO PRIVATE LEDGER CORP | $52,479.00 | 0.03 | 58,485 | +0.21% | +$112.16 | <0.0001 | |
Invesco | $50,567.00 | 0.03 | 56,355 | -3.33% | -$1,738.96 | <0.0001 | |
Bank of America | $46,819.00 | 0.03 | 52,195 | -71.1% | -$115,193.85 | <0.0001 | |
Wells Fargo | $45,620.00 | 0.03 | 50,842 | +22.85% | +$8,484.77 | <0.0001 | |
JPMorgan Chase | $45,964.00 | 0.03 | 51,224 | -35.77% | -$25,592.29 | <0.0001 | |
Miller Investment Management Lp | $44,865.00 | 0.03 | 50,000 | 0% | +$0 | 0.01 | |
Voya Investment Management LLC | $42,971.00 | 0.03 | 47,889 | -7.69% | -$3,578.45 | <0.0001 | |
SG Americas Securities, LLC | $37,000.00 | 0.02 | 41,020 | -34.96% | -$19,887.27 | <0.0001 | |
Private Advisor Group | $35,892.00 | 0.02 | 40,000 | 0% | +$0 | <0.0001 | |
T. Rowe Price | $28,000.00 | 0.02 | 30,231 | +7.46% | +$1,945.02 | <0.0001 | |
Tcg Advisory Services Llc | $26,919.00 | 0.02 | 30,000 | 0% | +$0 | <0.01 | |
Citigroup | $22,341.00 | 0.01 | 24,898 | +40.71% | +$6,464.16 | <0.0001 | |
ProShares | $21,687.00 | 0.01 | 24,169 | +18.82% | +$3,435.79 | <0.0001 | |
Group One Trading | $17,555.00 | 0.01 | 19,564 | -23.58% | -$5,417.97 | <0.0001 | |
Victory Capital Management Inc | $17,343.00 | 0.01 | 19,328 | -2.16% | -$382.25 | <0.0001 | |
Fidelity Investments | $15,949.00 | 0.01 | 17,774 | -4.09% | -$680.17 | <0.0001 | |
HSBC | $13,719.00 | 0.01 | 15,289 | New | +$13,719.00 | <0.0001 | |
Franklin Templeton Investments | $12,808.00 | 0.01 | 14,274 | 0% | +$0 | <0.0001 | |
Csenge Advisory Group | $13,460.00 | 0.01 | 15,000 | 0% | +$0 | <0.01 | |
CalSTRS | $12,134.00 | 0.01 | 13,523 | -33.15% | -$6,016.30 | <0.0001 | |
Susquehanna International Group | $10,070.00 | 0.01 | 11,223 | -92.04% | -$116,436.23 | <0.0001 | |
Legal & General | $10,433.00 | 0.01 | 11,673 | 0% | +$0 | <0.0001 | |
AllianceBernstein | $10,095.00 | 0.01 | 11,250 | 0% | +$0 | <0.0001 |